[Transplant Candidate with Cancer: Should We Proceed?]

Area of Science:

• Nephrology
• Oncology
• Immunology

Context:

• End-stage renal disease (ESRD) patients have a higher risk of developing tumors.
• Dialysis exacerbates malignancy incidence in ESRD patients.
• Kidney transplant recipients experience a transient decrease in cancer mortality, followed by a long-term increase.

Purpose:

• To analyze the complex relationship between kidney disease, transplantation, and cancer risk.
• To evaluate the impact of immunosuppressive therapy on neoplasm development post-transplant.
• To inform optimal timing for kidney transplantation after cancer remission.

Summary:

• ESRD and dialysis significantly increase cancer risk.
• Post-kidney transplant, cancer risk rises progressively, influenced by immunosuppression.
• Balancing cancer remission timelines with transplant candidacy is crucial for patient outcomes.

Impact:

• Highlights the need for careful oncological assessment in ESRD and transplant candidates.
• Emphasizes the dual role of immunosuppression in transplant management.
• Suggests revised protocols for managing cancer survivors awaiting kidney transplants to mitigate mortality and graft loss.